Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts

Fig. 3

Percentage of patients who, besides being classified as having systemic lupus erythematosus (SLE), also fulfilled the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis (RA) [43] provided they were: (1) anti-cyclic citrullinated peptide (anti-CCP) antibody-positive, (2) identified as citrulline-dependent anti-CCP antibody-positive (i.e. higher anti-CCP than cyclic arginine peptide (anti-CAP) antibody level), and (3) anti-carbamylated protein (anti-CarP) antibody-positive

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us